Exchange: OTC·Updated 09:31 AM EDT

About

Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Nymox Pharmaceutical Corp?
What is the 52-week high for Nymox Pharmaceutical Corp?
What is the 52-week low for Nymox Pharmaceutical Corp?
What is Nymox Pharmaceutical Corp stock price today?
What was Nymox Pharmaceutical Corp stock price yesterday?
What is the 50-day moving average of Nymox Pharmaceutical Corp?

Advertisement|Remove ads.